Loading clinical trials...
Loading clinical trials...
The tolerance of immune checkpoint inhibitors is unknown in patients with pre-existing autoimmune conditions. This retrospective nation-wide study will assess their tolerance in patients with pre-exis...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Brest
NCT06616298 · Advanced Cancer
NCT07362654 · Celiac Disease, Gluten Sensitivity, and more
NCT05735080 · Breast Cancer, Breast Cancer Metastatic, and more
NCT06948110 · Autoimmune Diseases
NCT04657068 · Advanced Cancer, Metastatic Cancer, and more
CH d'AIX
Aix-en-Provence
CHU de DIJON
Dijon
CHD Vendée
La Roche-sur-Yon
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions